Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Zylodine


Not recommended
Risk of bradycardia/tachycardia in foetus

May be acceptable
Zylodine :
Type Medicine Non Marketed
Originator Xylocaine Injectable 2%*
Agent Bellapharma
Distributor Bellapharma
Laboratory MS Pharma
Responsible Party MS Pharma
Origin Jordan
Manufacturer MS Pharma
Manufacturing Type G
Origin Jordan
ATC N01BB02

Your comment will appear shortly after approval

Zylodine :

Revision Date : 01/05/2016


Effect Frequency
Allergic reaction Rare
Anaphylactic shock Rare
Arachnoiditis Rare
Arrhythmia Rare
Bradycardia Common
Cardiac arrest Rare
Convulsion Uncommon
Diplopia Rare
Dysarthria Uncommon
Hyperacusis Uncommon
Hypertension Common
Hypotension Common
Nausea Common
Neuropathy Rare
Paraesthesia (paresthesia) Common
Perioral paraesthesia Uncommon
Respiratory depression Rare
Tinnitus Uncommon
Tremor Uncommon
Vertigo Common
Visual disturbance Uncommon
Vomiting Common

Different Units By MoH Code

Zylodine  MoH 9695 :
Form Solution for injection
Packaging Bottle
Package Size 50ml
Strength 2%
NSSF ✘
Quarantine ✘
Reg. Number 95617/1
Submission date 22/06/2017
Registration Year 10/09/2018
Archived Date 02/03/2023


Price Comparison

● Country: Jordan
● Package Size: 1x50ml
● Public Price: 1.86 JOD ( 232,911.06 LBP )
● Pack size unit used: 1
● Cost/Unit: 1,86 JOD ( 125,221.00 LBP )
● Reference: JFDA
● Pricing Date: 25/05/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info